CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total Precipio, Inc.	Noncontrolling Interest [Member]	Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018		$ 23	$ 53,796	$ (47,696)	$ 6,123		$ 6,123
Balance at beginning of period (in shares) at Dec. 31, 2018	47	2,298,738
Increase (Decrease) in Stockholders' Equity
Net (loss) income				(7,565)	(7,565)		(7,565)
Conversion of convertible notes into common stock		$ 24	7,248		7,272		7,272
Conversion of convertible notes into common stock (in shares)		2,386,425
Issuance of common stock in connection with purchase agreements		$ 10	2,400		2,410		2,410
Issuance of common stock in connection with purchase agreements (in shares)		998,076
Issuance of common stock upon exercise of warrants		$ 3	1,572		1,575		1,575
Issuance of common stock upon exercise of warrants (in shares)		310,200
Write-off warrant liability in conjunction with warrant exercises			2,364		2,364		2,364
Beneficial conversion feature on issuance of notes			1,792		1,792		1,792
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions			(527)		(527)		(527)
Write-off debt derivative liability in conjunction with convertible note conversions			477		477		477
Sock-based compensation			307		307		307
Payment of fractional common shares in conjunction with reverse stock split			(1)		(1)		(1)
Payment of fractional common shares in conjunction with reverse stock split (in shares)		(71)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019		$ 60	69,428	(55,261)	14,227		14,227
Balance at end of period (in shares) at Jun. 30, 2019	47	5,993,368
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018		$ 23	53,796	(47,696)	6,123		6,123
Balance at beginning of period (in shares) at Dec. 31, 2018	47	2,298,738
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2019		$ 79	74,065	(60,939)	13,205		13,205
Balance at end of period (in shares) at Dec. 31, 2019	47	7,898,117
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019		$ 43	59,138	(49,348)	9,833		9,833
Balance at beginning of period (in shares) at Mar. 31, 2019	47	4,304,929
Increase (Decrease) in Stockholders' Equity
Net (loss) income				(5,913)	(5,913)		(5,913)
Conversion of convertible notes into common stock		$ 12	4,134		4,146		4,146
Conversion of convertible notes into common stock (in shares)		1,138,310
Issuance of common stock in connection with purchase agreements		$ 2	682		684		684
Issuance of common stock in connection with purchase agreements (in shares)		240,000
Issuance of common stock upon exercise of warrants		$ 3	1,572		1,575		1,575
Issuance of common stock upon exercise of warrants (in shares)		310,200
Write-off warrant liability in conjunction with warrant exercises			2,364		2,364		2,364
Beneficial conversion feature on issuance of notes			1,792		1,792		1,792
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions			(842)		(842)		(842)
Write-off debt derivative liability in conjunction with convertible note conversions			438		438		438
Sock-based compensation			151		151		151
Payment of fractional common shares in conjunction with reverse stock split			(1)		(1)		(1)
Payment of fractional common shares in conjunction with reverse stock split (in shares)		(71)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019		$ 60	69,428	(55,261)	14,227		14,227
Balance at end of period (in shares) at Jun. 30, 2019	47	5,993,368
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019		$ 79	74,065	(60,939)	13,205		13,205
Balance at beginning of period (in shares) at Dec. 31, 2019	47	7,898,117
Increase (Decrease) in Stockholders' Equity
Net (loss) income				(5,454)	(5,454)	$ 17	(5,437)
Conversion of convertible notes into common stock		$ 39	2,137		2,176		2,176
Conversion of convertible notes into common stock (in shares)		3,908,145
Issuance of common stock in connection with purchase agreements		$ 28	2,579		2,607		2,607
Issuance of common stock in connection with purchase agreements (in shares)		2,810,654
Write-off beneficial conversion feature in conjunction with convertible note extinguishment			(523)		(523)		(523)
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions			270		270		270
Sock-based compensation			329		329		329
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020		$ 146	78,857	(66,393)	12,610	17	12,627
Balance at end of period (in shares) at Jun. 30, 2020	47	14,616,916
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020		$ 95	75,334	(64,144)	11,285		11,285
Balance at beginning of period (in shares) at Mar. 31, 2020	47	9,506,126
Increase (Decrease) in Stockholders' Equity
Net (loss) income				(2,249)	(2,249)	17	(2,232)
Conversion of convertible notes into common stock		$ 35	1,788		1,823		1,823
Conversion of convertible notes into common stock (in shares)		3,480,148
Issuance of common stock in connection with purchase agreements		$ 16	1,241		1,257		1,257
Issuance of common stock in connection with purchase agreements (in shares)		1,630,642
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions			333		333		333
Sock-based compensation			161		161		161
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020		$ 146	$ 78,857	$ (66,393)	$ 12,610	$ 17	$ 12,627
Balance at end of period (in shares) at Jun. 30, 2020	47	14,616,916